Literature DB >> 20653832

Urogenital complaints and female sexual dysfunction. Part 2.

Salim A Wehbe1, Susan Kellogg, Kristene Whitmore.   

Abstract

INTRODUCTION: Female sexual dysfunction (FSD) is common in women with urogenital disorders that occur as a result of pelvic floor muscle and fascial laxity. AIM: Provide a comprehensive review of FSD as it relates to common urogenital disorders including pelvic organ prolapse (POP) and stress urinary incontinence (SUI) and to discuss the impact of the surgical repair of these disorders on sexual function.
METHODS: Systematic search of the medical literature using a number of related terms including FSD, POP, SUI, surgical repair, graft augmentation, complications, and dyspareunia. MAIN OUTCOME MEASURES: Review of the medical literature to identify the relation between FSD and common urogenital disorders in women and to describe appropriate treatment strategies to improve quality of life (QOL) and sexual function.
RESULTS: FSD is common in women with POP and SUI. Treatment options for POP and SUI include behavioral, pharmacological, and surgical methods which can also affect sexual function.
CONCLUSIONS: Sexual dysfunction is a common, underestimated complaint in women with POP and SUI. Treatment should be tailored toward improving sexual function and QOL. Surgical correction is generally beneficial but occasionally can result in negative alterations in sexual function. Patient selection and methods used for surgical repair are important factors in determining anatomical and functional success.

Entities:  

Mesh:

Year:  2010        PMID: 20653832     DOI: 10.1111/j.1743-6109.2010.01951.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

1.  The impact of multimorbidity on sexual function in middle-aged and older women: beyond the single disease perspective.

Authors:  Ayesha A Appa; Jennifer Creasman; Jeanette S Brown; Stephen K Van Den Eeden; David H Thom; Leslee L Subak; Alison J Huang
Journal:  J Sex Med       Date:  2014-08-22       Impact factor: 3.802

2.  OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results.

Authors:  Antonella Giannantoni; Silvia Proietti; Guido Giusti; Marilena Gubbiotti; Enrico Millefiorini; Elisabetta Costantini; Alfredo Berardelli; Antonella Conte
Journal:  World J Urol       Date:  2015-05-13       Impact factor: 4.226

Review 3.  Urinary disorders and female sexual function.

Authors:  Jaclyn Chen; Genevieve Sweet; Alan Shindel
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

4.  Dyspareunia in HIV-positive and HIV-negative middle-aged women: a cross-sectional study.

Authors:  Ana L R Valadares; Aarão M Pinto-Neto; Debora de C Gomes; Walquíria C D'Avanzo; Alexandre S Moura; Lúcia Costa-Paiva; Maria Helena de Sousa
Journal:  BMJ Open       Date:  2014-11-24       Impact factor: 2.692

5.  Sexual function after anterior vaginal wall prolapse surgery.

Authors:  Paulo Cezar Feldner; Carlos Antonio Delroy; Sérgio Brasileiro Martins; Rodrigo Aquino Castro; Marair Gracio Ferreira Sartori; Manoel João Batista Castello Girão
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.